Filing Details
- Accession Number:
- 0001849521-23-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-06 17:21:55
- Reporting Period:
- 2023-12-06
- Accepted Time:
- 2023-12-06 17:21:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926617 | Aspira Women's Health Inc. | AWH | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1849521 | Nicole Sandford | C/O Aspira Women'S Health 12117 Bee Caves Rd Bldg 3-100 Austin TX 78738 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-06 | 5,000 | $3.36 | 58,703 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
